Hospital stocks slip after SC query on steep cancer drug markups
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓India's hospital stocks fell on Wednesday after the Supreme Court questioned steep markups on cancer drugs.
- ✓The BSE Hospitals Index fell 5% as the court asked the government to probe why hospitals force patients to buy medicines from specific pharmacies.
- ✓Major chains like Apollo and Fortis saw their shares drop.
Story at a Glance
- Category
- MARKET
- Reported By
- The Economic Times
- Reading Speed
- 6 Minute(s)
- Market Focus
- India Economy
Synopsis
In a landmark ruling, the Supreme Court of India highlighted troubling markups on cancer drugs enforced by hospitals, urging a probe into reports of patients being directed to specific pharmacies for their medications. Following this announcement, the BSE Hospitals Index faced a steep 5% drop, leading to notable losses for industry giants like Apollo Hospitals and Fortis Healthcare.
Mumbai: India's hospital stocks came under pressure on Wednesday after the Supreme Court questioned steep markups on cancer drugs and asked the government to examine allegations that hospitals require patients to buy medicines from their own or designated pharmacies.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
The Economic Times
Read the full, original unfiltered story directly on the publisher's portal.